We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Rerouting Nerves During Amputation Reduces Phantom Limb Pain

By HospiMedica International staff writers
Posted on 09 Jan 2019
Image: A new study asserts that redirecting nerves severed during limb amputation can reduce phantom pain (Photo courtesy of 123rf).
Image: A new study asserts that redirecting nerves severed during limb amputation can reduce phantom pain (Photo courtesy of 123rf).
A novel surgical procedure developed for advanced prosthetics can prevent or reduce debilitating phantom limb and stump pain in amputees, according to a new study.

Researchers at Ohio State University (OSU; Columbus, USA) conducted a study in 22 patients in order to evaluate the results of primary targeted muscle reinnervation (TMR) for below-the-knee amputations. The procedure involves rerouting the severed motor nerves by surgically transferring them to the motor points of the denervated target muscles, which, after reinnervation, can contract in response to neural control signals intended for the missing limb. The operation of the prosthesis thus occurs in response to attempts to move the missing limb, making control easier and more intuitive.

All subjects denied neuroma pain following amputation. Each patient was followed on an outpatient basis for one year to evaluate early symptoms of neuroma or phantom limb pain, patient satisfaction, and functionality. The researchers also found that over the course of three years, none of the patients developed symptomatic neuromas, and only 13% of those who received primary TMR reported pain six months later. In addition, by creating the additional control sites, TMR eliminated the need to switch the prosthesis between different control modes. The study was published in the January 2019 issue of Plastic and Reconstructive Surgery.

“A significant amount of pain in amputees is caused by disorganized nerve endings, i.e. symptomatic neuromas, in the residual limb. They form when nerves are severed and not addressed, thus they have nowhere to go,” said senior author Ian Valerio, MD, of the department of plastic and reconstructive surgery at OSU. “Attaching those cut nerve endings to motor nerves in a nearby muscle allows the body to re-establish its neural circuitry. This alleviates phantom and residual limb pain by giving those severed nerves somewhere to go and something to do.”

“TMR allows for more individual muscle unit firings through the patient's thoughts. It provides for better intuitive control, resulting in more refined functional movements and more degrees of motion by an advanced prosthetic,” concluded lead author J. Byers Bowen, MD, of OSU. “When done at the time of initial amputation, there is minimal health risk, and recovery is similar to that of traditional amputation surgery.”

Approximately 25% of major limb amputees will develop chronic localized symptomatic neuromas and phantom limb pain in the residual stump or limb. Previous studies show that secondary targeted reinnervation successfully treats and, in some cases, resolves peripheral neuropathy and phantom limb pain in patients who have undergone a previous amputation.

Related Links:
Ohio State University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
High Pressure Balloon Catheter
UroMax Ultra
New
Endoscopy Display
E190

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more